In this randomized controlled trial, it was found that GA2, a late-arresting, genetically attenuated Plasmodium falciparum ...

SK bioscience will assess the safety and immunogenicity of the therapy in 402 healthy adult subjects in Australia.

Sarah Schillie, M.D., from the CDC in Atlanta, and colleagues present the updated recommendations of the ACIP for the Bexsero ...

mRNA vaccines clearly saved lives during the COVID-19 pandemic, but several studies suggest that older people had a somewhat ...

Africa saw a notable jump in mpox cases last week, with a continuing rise in novel clade 1b detections and shifts in ...

The global bioanalytical testing services market has witnessed significant growth in recent years, driven by advancements in ...

Drug candidate selected for ABS-201, a novel, potentially category-defining anti-PRLR antibody in development for androgenic alopeciaLeading AI ...

SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim ...

Assessing immunogenicity is a cornerstone of modern drug development, especially for biologics and vaccines. Understanding ...

The following is a summary of “First-in-class bispecific antibody IBI318 (LY3434172) targeting PD-1 and PD-L1 in patients ...

Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, ...

Bioinformatic methods of network modelling and integrative data analysis work towards finding molecular patterns that describe active signalling pathways and identifying antigenic determinants that ...